Dr. Lal PathLabs Ltd. Announces Completion of Tenure for Independent Director Gurinder Singh Kalra
Dr. Lal PathLabs Limited has announced that Mr. Gurinder Singh Kalra, holding DIN: 10197218, has concluded his tenure as an Independent Director of the company. The cessation of his directorship became effective on July 26, 2026 (closing business hours).The change in board composition is attributed to the completion of his designated tenure as an Independent Director. This operational update provides details regarding the director's status and the reason for the change.
Key details concerning the cessation are provided below:
| Particulars | Details |
|---|---|
| Director Name | Mr. Gurinder Singh Kalra (DIN: 10197218) |
| Date of Cessation | July 26, 2026 |
| Reason for Change | Completion of tenure as Independent Director of the Company |
LALPATHLAB Stock Price Movement
On Friday, shares of Dr. Lal Path Labs Ltd. surged by 5.21% to close at ₹1759.20, driven by stellar performance near its annual high. The stock saw robust activity with 1.45 million shares traded as the company concluded the session on a strong upward trajectory.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.